Copyright: ©Author(s) 2026.
World J Exp Med. Jun 20, 2026; 16(2): 121046
Published online Jun 20, 2026. doi: 10.5493/wjem.v16.i2.121046
Published online Jun 20, 2026. doi: 10.5493/wjem.v16.i2.121046
Table 2 Pathophysiological mechanisms of pulmonary embolism in relation to Mendelian randomization evidence
| Mechanism | Description | Clinical relevance | MR-informed associations |
| Thrombus formation | Formation of clots in deep veins driven by Virchow’s triad: Endothelial injury, hypercoagulability, and venous stasis | Risk of embolization to the pulmonary circulation; prevention primarily via anticoagulation | MR-specific associations not directly evaluated |
| Pulmonary vascular obstruction | Occlusion of pulmonary arteries leading to increased vascular resistance and right ventricular afterload | May result in right ventricular dysfunction and hemodynamic instability requiring urgent intervention | Renal dysfunction (reduced eGFR) associated with increased PE susceptibility |
| Gas exchange impairment | Ventilation-perfusion mismatch resulting in hypoxemia due to increased dead space ventilation | Manifests as dyspnea and hypoxemia; supportive oxygen therapy required | Obesity-related metabolic traits show variable MR associations |
| Inflammatory response | Cytokine release, NET formation, and oxidative stress contribute to thromboinflammation | Potential role of anti-inflammatory pathways in disease modulation | Reduced HLA-DR-positive NK cell traits associated with increased PE risk |
| Endothelial dysfunction | Endothelial injury promotes activation of coagulation pathways and thrombus formation | May contribute to chronic thromboembolic pulmonary hypertension | MMP19 associated with increased PE risk; MMP12 shows inverse association |
| Metabolic dysregulation | Obesity and metabolic imbalance promote a pro-inflammatory and prothrombotic state | May influence risk stratification and long-term outcomes | BMI and gut microbiota traits show variable MR associations |
| Coagulation cascade activation | Activation of clotting pathways through tissue factor exposure and thrombin generation | Guides use of anticoagulant therapies | Not directly evaluated in MR studies included in this review |
- Citation: Desai R, Patel D, Prasad A, Mandalapu N, Nagarajan J, Guddeti A, Khatri S, Shahnawaz W, Aleem A, Mohammed AS, Yasmeen U, Ghani MU. Genetic and biological determinants of pulmonary embolism: Insights from Mendelian randomization studies. World J Exp Med 2026; 16(2): 121046
- URL: https://www.wjgnet.com/2220-315X/full/v16/i2/121046.htm
- DOI: https://dx.doi.org/10.5493/wjem.v16.i2.121046